Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Intriguingly, PAR2 deficiency significantly aggravated colitis and promoted tumor development in AOM/DSS model.
|
31733286 |
2020 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The colitis-associated tumor model comprised a single injection of AOM, followed by cycles of drinking water with dissolved dextran sodium sulfate salt (AOM-DSS model).
|
31072353 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In the current study, we revealed that AVN A notably attenuated tumor formation in an azoxymethane/dextran sulfate sodium (AOM/DSS) mouse model.
|
30888162 |
2019 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Triptolide reduced both tumor number and tumor size in adenomatous polyposis coli (Apc) mutated (Apc<sup>Min/+</sup>) mice as well as AOM/DSS-induced mice.
|
31122284 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice.
|
30804114 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, upregulation of PIAS3 by intracolonic administration of PIAS3 lentivirus or anti-miR-18a lentivirus in AOM-DSS-induced mice led to dramatically reduced tumor sizes/numbers, whereas knockdown of PIAS3 in CAC mice significantly promoted tumor growth.
|
29896300 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Supplementation of IL-18 or transfer of wild-type myeloid cells reduced tumor burden in AOM-DSS-treated Card9<sup>-/-</sup> and Syk<sup>fl/fl</sup>LysM<sup>Cre/+</sup> mice, whereas treatment with anti-fungal agents exacerbated colitis and CRC.
|
30231985 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Meanwhile, silibinin decreased the amount and size of tumors in AOM/DSS mice.
|
30498394 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
VSL#3 significantly reduced the tumor load in AOM/DSS-induced mice model and decreased the level of TNF-α and IL-6 in colon tissue.
|
30310258 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
High-fat diet (HFD) significantly enhanced tumor growth in vivo, and was associated with a shorter intestinal length in azoxymethane/dextran sodium sulfate (AOM/DSS)-treated mice.
|
28618417 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The increased tumor burden in Mbd4-/- mice did not arise from impairment of AOM-induced apoptosis in the intestinal crypt.
|
27086921 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Interestingly, stromal deletion of Imp1 (Dermo1Cre;Imp1(LoxP/LoxP), or Imp1(ΔMes)) in the azoxymethane/dextran sodium sulfate (AOM/DSS) model of colitis-associated cancer resulted in increased tumor numbers of larger size and more advanced histologic grade than controls.
|
26194191 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Colibactin-producing E. coli enhanced tumour growth in both xenograft and AOM/DSS models.
|
24658599 |
2014 |